235 related articles for article (PubMed ID: 18416663)
1. SPECT and PET of the dopamine transporter in attention-deficit/hyperactivity disorder.
Krause J
Expert Rev Neurother; 2008 Apr; 8(4):611-25. PubMed ID: 18416663
[TBL] [Abstract][Full Text] [Related]
2. Genetic imaging study with [Tc-
Akay AP; Kaya GÇ; Kose S; Yazıcıoğlu ÇE; Erkuran HÖ; Güney SA; Oğuz K; Keskin D; Baykara B; Emiroğlu Nİ; Eren MŞ; Kızıldağ S; Ertay T; Özsoylu D; Miral S; Durak H; Gönül AS; Rohde LA
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():294-300. PubMed ID: 29684537
[TBL] [Abstract][Full Text] [Related]
3. Low dopamine transporter occupancy by methylphenidate as a possible reason for reduced treatment effectiveness in ADHD patients with cocaine dependence.
Crunelle CL; van den Brink W; Veltman DJ; van Emmerik-van Oortmerssen K; Dom G; Schoevers RA; Booij J
Eur Neuropsychopharmacol; 2013 Dec; 23(12):1714-23. PubMed ID: 23731497
[TBL] [Abstract][Full Text] [Related]
4. Methylphenidate DAT binding in adolescents with Attention-Deficit/ Hyperactivity Disorder comorbid with Substance Use Disorder--a single photon emission computed tomography with [Tc(99m)]TRODAT-1 study.
Szobot CM; Shih MC; Schaefer T; Júnior N; Hoexter MQ; Fu YK; Pechansky F; Bressan RA; Rohde LA
Neuroimage; 2008 Apr; 40(3):1195-201. PubMed ID: 18282769
[TBL] [Abstract][Full Text] [Related]
5. The homozygosity for 10-repeat allele at dopamine transporter gene and dopamine transporter density in Korean children with attention deficit hyperactivity disorder: relating to treatment response to methylphenidate.
Cheon KA; Ryu YH; Kim JW; Cho DY
Eur Neuropsychopharmacol; 2005 Jan; 15(1):95-101. PubMed ID: 15572278
[TBL] [Abstract][Full Text] [Related]
6. Molecular imaging genetics of methylphenidate response in ADHD and substance use comorbidity.
Szobot CM; Roman T; Hutz MH; Genro JP; Shih MC; Hoexter MQ; Júnior N; Pechansky F; Bressan RA; Rohde LA
Synapse; 2011 Feb; 65(2):154-9. PubMed ID: 20593420
[TBL] [Abstract][Full Text] [Related]
7. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity.
Jucaite A; Fernell E; Halldin C; Forssberg H; Farde L
Biol Psychiatry; 2005 Feb; 57(3):229-38. PubMed ID: 15691523
[TBL] [Abstract][Full Text] [Related]
8. Value of 99mTc-TRODAT-1 SPECT to predict clinical response to methylphenidate treatment in adults with attention deficit hyperactivity disorder.
la Fougère C; Krause J; Krause KH; Josef Gildehaus F; Hacker M; Koch W; Hahn K; Tatsch K; Dresel S
Nucl Med Commun; 2006 Sep; 27(9):733-7. PubMed ID: 16894328
[TBL] [Abstract][Full Text] [Related]
9. Availability of dopamine transporters and auditory P300 abnormalities in adults with attention-deficit hyperactivity disorder: preliminary results.
Chu CL; Lee IH; Chi MH; Chen KC; Chen PS; Yao WJ; Chiu NT; Yang YK
CNS Spectr; 2018 Aug; 23(4):264-270. PubMed ID: 28847342
[TBL] [Abstract][Full Text] [Related]
10. Attention deficit hyperactivity disorder: binding of [99mTc]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment.
Dresel S; Krause J; Krause KH; LaFougere C; Brinkbäumer K; Kung HF; Hahn K; Tatsch K
Eur J Nucl Med; 2000 Oct; 27(10):1518-24. PubMed ID: 11083541
[TBL] [Abstract][Full Text] [Related]
11. Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder.
Volkow ND; Wang GJ; Newcorn J; Telang F; Solanto MV; Fowler JS; Logan J; Ma Y; Schulz K; Pradhan K; Wong C; Swanson JM
Arch Gen Psychiatry; 2007 Aug; 64(8):932-40. PubMed ID: 17679638
[TBL] [Abstract][Full Text] [Related]
12. Long-term stimulant treatment affects brain dopamine transporter level in patients with attention deficit hyperactive disorder.
Wang GJ; Volkow ND; Wigal T; Kollins SH; Newcorn JH; Telang F; Logan J; Jayne M; Wong CT; Han H; Fowler JS; Zhu W; Swanson JM
PLoS One; 2013; 8(5):e63023. PubMed ID: 23696790
[TBL] [Abstract][Full Text] [Related]
13. Brain dopamine transporter levels in treatment and drug naïve adults with ADHD.
Volkow ND; Wang GJ; Newcorn J; Fowler JS; Telang F; Solanto MV; Logan J; Wong C; Ma Y; Swanson JM; Schulz K; Pradhan K
Neuroimage; 2007 Feb; 34(3):1182-90. PubMed ID: 17126039
[TBL] [Abstract][Full Text] [Related]
14. Attention deficit/hyperactivity disorder: is there a correlation between dopamine transporter density and cerebral blood flow?
da Silva N; Szobot CM; Anselmi CE; Jackowski AP; Chi SM; Hoexter MQ; Anselmi OE; Pechansky F; Bressan RA; Rohde LA
Clin Nucl Med; 2011 Aug; 36(8):656-60. PubMed ID: 21716015
[TBL] [Abstract][Full Text] [Related]
15. Striatal dopamine transporter availability and DAT-1 gene in adults with ADHD: no higher DAT availability in patients with homozygosity for the 10-repeat allele.
Krause J; Dresel SH; Krause KH; La Fougère C; Zill P; Ackenheil M
World J Biol Psychiatry; 2006; 7(3):152-7. PubMed ID: 16861140
[TBL] [Abstract][Full Text] [Related]
16. Dopamine transporter density in the basal ganglia assessed with [123I]IPT SPET in children with attention deficit hyperactivity disorder.
Cheon KA; Ryu YH; Kim YK; Namkoong K; Kim CH; Lee JD
Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):306-11. PubMed ID: 12552351
[TBL] [Abstract][Full Text] [Related]
17. Searching for a neurobiological basis for self-medication theory in ADHD comorbid with substance use disorders: an in vivo study of dopamine transporters using (99m)Tc-TRODAT-1 SPECT.
Silva N; Szobot CM; Shih MC; Hoexter MQ; Anselmi CE; Pechansky F; Bressan RA; Rohde LA
Clin Nucl Med; 2014 Feb; 39(2):e129-34. PubMed ID: 23856832
[TBL] [Abstract][Full Text] [Related]
18. The dopamine transporter and neuroimaging in attention deficit hyperactivity disorder.
Krause KH; Dresel SH; Krause J; la Fougere C; Ackenheil M
Neurosci Biobehav Rev; 2003 Nov; 27(7):605-13. PubMed ID: 14624805
[TBL] [Abstract][Full Text] [Related]
19. Influence of striatal dopamine transporter availability on the response to methylphenidate in adult patients with ADHD.
Krause J; la Fougere C; Krause KH; Ackenheil M; Dresel SH
Eur Arch Psychiatry Clin Neurosci; 2005 Dec; 255(6):428-31. PubMed ID: 16091862
[TBL] [Abstract][Full Text] [Related]
20. Methylation of the dopamine transporter gene in blood is associated with striatal dopamine transporter availability in ADHD: A preliminary study.
Wiers CE; Lohoff FW; Lee J; Muench C; Freeman C; Zehra A; Marenco S; Lipska BK; Auluck PK; Feng N; Sun H; Goldman D; Swanson JM; Wang GJ; Volkow ND
Eur J Neurosci; 2018 Aug; 48(3):1884-1895. PubMed ID: 30033547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]